Catalyst Pharmaceutical Partners Inc buy Truist Financial Co.
Start price
11.11.24
/
50%
€22.00
Target price
11.11.25
€33.80
Performance (%)
-10.57%
End price
12.11.25
€19.68
Summary
This prediction ended on 12.11.25 with a price of €19.68. The price of Catalyst Pharmaceutical Partners Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.57%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -0.396% | -0.396% | -1.324% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Truist Financial Co. from $30.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.68
09.08.24
09.08.24
€27.48
09.08.25
09.08.25
1.02%
10.08.25
10.08.25
